Holen Sie sich die Stockscreener-App
25.55
2.14%
-0.56
Handel nachbörslich:
25.80
0.25
+0.98%
Xoma Royalty Corp Aktie (XOMA) Neueste Nachrichten
XOMA (NASDAQ:XOMA) Cut to Sell at StockNews.com - MarketBeat
HC Wainwright Issues Pessimistic Forecast for XOMA (NASDAQ:XOMA) Stock Price - MarketBeat
XOMA stock price target cut to $104 by H.C. Wainwright - MSN
HC Wainwright Has Lowered Expectations for XOMA (NASDAQ:XOMA) Stock Price - Defense World
StockNews.com Downgrades XOMA (NASDAQ:XOMA) to Sell - Defense World
XOMA Royalty to Present at Oppenheimer 35th Annual Healthcare Life Sciences Conference - GlobeNewswire
Exclusive Healthcare Insights: XOMA Leadership Takes Center Stage at Oppenheimer Conference - StockTitan
XOMA (NASDAQ:XOMAP) Trading Up 0.4% – Should You Buy? - Defense World
Forecasting The Future: 5 Analyst Projections For XOMA Royalty - Benzinga
XOMA Co. (NASDAQ:XOMA) Major Shareholder Bvf Partners L. P/Il Sells 500,742 Shares - MarketBeat
Short Interest in XOMA Co. (NASDAQ:XOMAO) Decreases By 34.2% - Defense World
Xoma royalty corp sees sale of $16.98 million in stock by investors - MSN
BIOTECHNOLOGY VALUE FUND L P Reduces Stake in XOMA Royalty Corp - GuruFocus.com
Xoma royalty corp sees sale of $16.98 million in stock by investors By Investing.com - Investing.com India
Barclays PLC Has $298,000 Stake in XOMA Co. (NASDAQ:XOMA) - Defense World
XOMA (NASDAQ:XOMA) Upgraded at StockNews.com - MarketBeat
XOMA (NASDAQ:XOMA) Stock Rating Upgraded by StockNews.com - Defense World
XOMA Royalty Corporation: High-Risk Royalty Aggregator Best Avoided - Seeking Alpha
XOMA (NASDAQ:XOMA) and Oragenics (NYSE:OGEN) Head to Head Review - Defense World
Xoma Royalty's chief investment officer buys $13,974 in stock By Investing.com - Investing.com Australia
XOMA (NASDAQ:XOMAP) Trading Down 0.8% – Here’s Why - Defense World
XOMA (NASDAQ:XOMA) Earns “Buy” Rating from HC Wainwright - Defense World
XOMA shares gain momentum, analyst notes 10%+ revenue growth potential from RZ358 - Investing.com
XOMA (NASDAQ:XOMA) Downgraded by StockNews.com to Sell - MarketBeat
HC Wainwright Reiterates "Buy" Rating for XOMA (NASDAQ:XOMA) - MarketBeat
Barclays PLC Acquires 8,447 Shares of XOMA Co. (NASDAQ:XOMA) - Defense World
Geode Capital Management LLC Purchases 1,138 Shares of XOMA Co. (NASDAQ:XOMA) - Defense World
State Street Corp Has $3.78 Million Holdings in XOMA Co. (NASDAQ:XOMA) - Defense World
Short Interest in XOMA Co. (NASDAQ:XOMAO) Grows By 26.7% - Defense World
XOMA Co. (NASDAQ:XOMA) Sees Significant Growth in Short Interest - Defense World
XOMA (NASDAQ:XOMA) Lowered to “Sell” Rating by StockNews.com - Defense World
XOMA (NASDAQ:XOMA) Lowered to "Sell" Rating by StockNews.com - MarketBeat
BNP Paribas Financial Markets Purchases 795 Shares of XOMA Co. (NASDAQ:XOMA) - Defense World
XOMA Royalty Declares Quarterly Preferred Stock Dividends - GlobeNewswire
XOMA Royalty Declares Quarterly Preferred Stock Dividends for Series A and B Shares - StockTitan
XOMA (NASDAQ:XOMA) Earns Buy Rating from HC Wainwright - Defense World
XOMA (NASDAQ:XOMAP) Trading Down 0.6% – Should You Sell? - Defense World
XOMA (NASDAQ:XOMA) Receives Buy Rating from HC Wainwright - MarketBeat
XOMA Co. (NASDAQ:XOMAO) Sees Significant Increase in Short Interest - Defense World
XOMA Co. (NASDAQ:XOMA) Shares Sold by Fmr LLC - MarketBeat
A Glimpse Into The Expert Outlook On XOMA Royalty Through 4 Analysts - Benzinga
XOMA shares target boosted, retains buy on new acquisition By Investing.com - Investing.com South Africa
XOMA Royalty’s Pulmokine brings seralutinib to pipeline - The Pharma Letter
XOMA shares target boosted, retains buy on new acquisition - Investing.com
Senti Bio’s Phase 1 CAR-NK data; Allink raises $42M - Endpoints News
Xoma Royalty acquires Pulmokine for $20M - TipRanks
XOMA Royalty Acquires Pulmokine for $20 Million Adding the Royalty and Milestone Interest in - The Bakersfield Californian
1.03%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):